The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-1991
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment ; volume:10 ; number:1 ; day:21 ; month:5 ; year:2020 ; pages:1-15 ; date:12.2020
Health economics review ; 10, Heft 1 (21.5.2020), 1-15, 12.2020
- Klassifikation
-
Wirtschaft
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13561-020-00267-y
- URN
-
urn:nbn:de:101:1-2020072721500070288377
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wettstein, Dominik J.
- Boes, Stefan
- SpringerLink (Online service)
Ähnliche Objekte (12)
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
MISSION FIELD REIMBURSEMENT FILE
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Legal Cost Insurance as a Strategic Device in Settlement Negotiations
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
MISSION FIELD REIMBURSEMENT FILE
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Legal Cost Insurance as a Strategic Device in Settlement Negotiations
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
MISSION FIELD REIMBURSEMENT FILE
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors